APRIL 29, 2022:
WASHINGTON (AP) — The Food and Drug Administration has set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children. The FDA said Friday (April 29, 2022) it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for vaccines in tots and babies. The dates are tentative and regulators said they will provide more details later. The meeting announcements follow months of frustration from families impatient for a chance to vaccinate their young children, along with complaints from politicians bemoaning the slow pace of the process.
APRIL 28, 2022:
UNDATED (AP)- Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation’s youngest children. Kids under 5 are the only group in the U.S. not yet eligible for vaccination, and frustrated parents are waiting impatiently for a chance to protect them. Moderna hopes the Food and Drug Administration will rule in time for tots to start getting vaccinated by summer. It’s a complex decision partly because while other countries give Moderna shots to older children, the U.S. so far has restricted them to adults. Rival Pfizer also is studying its vaccine in the littlest kids.
Comments